| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2017 | RDNT Radnet, Inc. | Crues John V | Medical Director | Sell | 19,684 | $10.01 | $196,962.04 | -3.5% | |
| Dec 18, 2017 | A Agilent Technologies, Inc. | Doak Mark | Sr. Vice President | Sell | 15,567 | $68.00 | $1,058,556.00 | -10.3% | |
| Dec 15, 2017 | WAT Waters Corp /de/ | Terricciano David | SVP, Global Operations | Sell | 21,997 | $197.52 | $4,344,830.62 | -53.6% | |
| Dec 15, 2017 | RVTY Revvity, Inc. | Okun Andrew76 | Please See Remarks | Sell | 12,680 | $72.00 | $912,960.00 | -50.5% | |
| Dec 15, 2017 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chief Executive Officer | Sell | 50,000 | $191.74 | $9,586,892.22 | -4.3% | |
| Dec 14, 2017 | BIO Bio-Rad Laboratories, Inc. | Tsingos Christine A | EVP And CFO | Sell | 4,980 | $249.40 | $1,242,019.97 | -42.7% | |
| Dec 14, 2017 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 5,000 | $9.71 | $48,541.30 | -0.7% | |
| Dec 14, 2017 | MYGN Myriad Genetics Inc | Gilbert Walter Phd | Director | Sell | 7,500 | $33.19 | $248,925.00 | -21.6% | |
| Dec 13, 2017 | WAT Waters Corp /de/ | Cassis Eugene G | SVP | Sell | 23,863 | $197.53 | $4,713,691.13 | -28.3% | |
| Dec 13, 2017 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 10,000 | $9.87 | $98,670.00 | -1.3% | |
| Dec 13, 2017 | WAT Waters Corp /de/ | Kelly Terrence P | SVP, President Ta Instruments | Sell | 25,000 | $197.63 | $4,940,754.24 | -49.2% | |
| Dec 12, 2017 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 10,000 | $9.82 | $98,230.00 | -1.3% | |
| Dec 11, 2017 | MYGN Myriad Genetics Inc | Dreismann Heinrich | Director | Sell | 6,000 | $33.50 | $201,000.00 | -15.1% | |
| Dec 11, 2017 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 7,500 | $9.68 | $72,567.50 | -0.9% | |
| Dec 8, 2017 | WST West Pharmaceutical Services Inc | Federici William J | Sr. VP &CFO | Sell | 21,000 | $99.01 | $2,079,210.00 | -9.9% | |
| Dec 8, 2017 | CDNA Caredx, Inc. | Yee James P | Chief Medical Officer | Sell | 29,197 | $7.00 | $204,379.00 | -39.0% | |
| Dec 7, 2017 | RVTY Revvity, Inc. | Wilson Frank Anders | Please See Remarks | Sell | 37,535 | $70.14 | $2,632,704.90 | -36.6% | |
| Dec 6, 2017 | CRL Charles River Laboratories International, Inc. | Reese C Richard | Director | Sell | 10,227 | $102.40 | $1,047,244.80 | -15.3% | |
| Dec 6, 2017 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 5,000 | $9.72 | $48,615.00 | -1.2% | |
| Dec 6, 2017 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 121,849 | $53.45 | $6,513,178.58 | -6.7% | |
| Dec 5, 2017 | A Agilent Technologies, Inc. | Doak Mark | Sr. Vice President | Sell | 4,154 | $67.00 | $278,318.00 | -5.7% | |
| Dec 5, 2017 | WAT Waters Corp /de/ | Miller William J | Director | Sell | 3,500 | $194.94 | $682,290.00 | -13.5% | |
| Dec 5, 2017 | MEDP Medpace Holdings, Inc. | Medpace Limited Partnership | 10% Owner | Sell | 4,600,000 | $30.16 | $138,741,980.00 | -21.9% | |
| Dec 4, 2017 | BIO Bio-Rad Laboratories, Inc. | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 1,000 | $258.39 | $258,394.70 | -28.6% | |
| Dec 4, 2017 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 5,000 | $10.00 | $50,010.00 | -1.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.